Basal ganglia neuronal discharge in primary and secondary dystonia.
D000200:Action Potentials / Q000502:physiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D002648:Child; D020821:Dystonic Disorders / Q000503:physiopathology* / Q000601:surgery; D004558:Electric Stimulation; D004594:Electrophysiology / Q000379:methods; D005260:Female; D005917:Globus Pallidus / Q000503:physiopathology* / Q000601:surgery*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging / Q000295:instrumentation / Q000379:methods; D008297:Male; D008875:Middle Aged; D018832:Molecular Chaperones; D009474:Neurons / Q000145:classification / Q000502:physiology*; D020734:Parkinsonian Disorders / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D011699:Putamen / Q000166:cytology / Q000503:physiopathology / Q000601:surgery; D016896:Treatment Outcome
D002352:Carrier Proteins; D018832:Molecular Chaperones; C108175:TOR1A protein, human; D007980:Levodopa